Land: Storbritannien
Sprog: engelsk
Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)
Mefenamic acid
Essential Generics Ltd
M01AG01
Mefenamic acid
500mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 10010100; GTIN: 5050204100292
_Continued over page_ PACKAGE LEAFLET: INFORMATION FOR THE USER PONSTAN FORTE 500 MG TABLETS mefenamic acid 7/L/x/2 OTHER MEDICINES AND PONSTAN FORTE Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Some medicines may be affected by Ponstan Forte or they may affect how well Ponstan Forte will work. Tell your doctor or pharmacist if you are taking: medicines that can increase the chance of getting ulcers or a bleed in the stomach or gut, such as: - corticosteroids used to treat arthritis and inflammation - medicines such as anti-platelet agents, used to thin the blood (e.g. warfarin, aspirin, clopidogrel) - antidepressants called selective serotonin re-uptake inhibitors (SSRIs) (e.g. paroxetine) - any other anti-inflammatory medicines (e.g. diclofenac, celecoxib) aspirin including low doses of aspirin used to prevent your blood from clotting in certain heart conditions medicines used for high blood pressure (e.g. atenolol, ramipril, valsartan) diuretics (water tablets) or heart medicines (e.g. digoxin, sotalol, diltiazem) some diabetic medicines (e.g. glipizide, glibenclamide) medicines which suppress the immune system (e.g. ciclosporin, tacrolimus, methotrexate) lithium, a medicine used to treat mood swings and some types of depression a medicine usually prescribed through hospitals, called mifepristone (taken within the last 12 days) quinolone antibiotics (antibiotics used to treat infections) aminoglycoside antibiotics, used under medical supervision in hospitals zidovudine, a medicine used for HIV probenecid, a medicine used in special cases, to protect the kidneys medicines which bind to protein in the blood - (check with your pharmacist). PONSTAN WITH ALCOHOL Avoid drinking alcohol. It may increase your risk of stomach bleeding. PREGNANCY, BREAST-FEEDING AND FERTILITY If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before takin Læs hele dokumentet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ponstan™ Forte Tablets 500mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 500 mg mefenamic acid Excipients with known effect Each tablet contains 22.73 mg lactose monohydrate and 0.067 mg sunset yellow (E 110). For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet Yellow, biconvex elliptical film coated tablet, inscribed ‘Ponstan Forte’ on one side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Mefenamic acid is a non-steroidal anti-inflammatory agent with analgesic properties, and a demonstrable antipyretic effect. It has been shown to inhibit prostaglandin activity. INDICATIONS 1. As an anti-inflammatory analgesic for the symptomatic relief of rheumatoid arthritis (including Still’s Disease), osteoarthritis, and pain including muscular, traumatic and dental pain, headaches of most aetiology, post-operative and post-partum pain. 2. Primary dysmenorrhoea. 3. Menorrhagia due to dysfunctional causes and presence of an IUD when other pelvic pathology has been ruled out. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4). Do not exceed the stated dose. Posology ADULTS 1 tablet (500 mg) three times daily. In menorrhagia to be administered on the first day of excessive bleeding and continued according to the judgement of the physician. In dysmenorrhoea to be administered at the onset of menstrual pain and continued according to the judgement of the physician. ELDERLY (OVER 65 YEARS) As for adults. Whilst no pharmacokinetic or clinical studies specific to the elderly have been undertaken with Ponstan Forte, it has been used at normal dosage in trials which included many elderly patients. The elderly are at increased risk of the serious consequences of adverse reactions. If an NSAID is considered necessary, the lowest effective dose should be used and f Læs hele dokumentet